About
LiquidCell Dx develops a liquid biopsy platform that non-invasively profiles the tumor and its microenvironment from blood samples to improve cancer treatment prediction and monitoring using AI-driven spatial ecosystem analysis.
Explore LiquidCell Dx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.